Virtual International COVID-19 and Diabetes Summit

Meeting Agenda

Wednesday, August 26, 2020

8:00     Opening Remarks

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California

8:05     Keynote

Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA

Session 1: Preparedness

Background

Moderator

Juan Espinoza, MD, FAACP
Children's Hospital Los Angeles, USC, Los Angeles, California, USA

8:15     Historic Pandemics and Impact on Society

Thomas Ewing, PhD
Virginia Tech University, Blacksburg, Virginia, USA

Christopher McKnight Nichols, PhD
Oregon State University, Corvallis, Oregon, USA

8:45     Pathophysiology / Risk Factors for COVID-19

Simin Liu, MD, ScD, MPH, MS
Brown University, Providence, Rhode Island, USA

Darin Olson, MD, PhD
Emory University, Atlanta, Georgia, USA

George Rutherford, III, MD, MA
UCSF, San Francisco, California, USA

9:45     Social Determinants of COVID-19

Kristin Bennet, PhD
Rensselaer Polytechnic Institute, Troy, New York, USA

Eliseo J. Pérez-Stable, MD
Director of National Institute on Minority Health and Health Disparities, NIH,
Bethesda, Maryland, USA

10:05   Break

Resilience

Moderator

Bithika Thompson, MD
Mayo Clinic Arizona, Scottsdale, Arizona, USA

10:30   Preparing for the Future

Amesh Adalja, MD
Johns Hopkins University, Baltimore, Maryland, USA

10:50   Medications and Vaccines

Evan Martin Bloch, MB, ChB, MS
Johns Hopkins University, Baltimore, Maryland, USA

Daniel Griffin, MD, PhD
Columbia University, New York, New York, USA

David Kaslow, MD
PATH, Seattle, Washington, USA

Nevan Krogan, PhD
UCSF, San Francisco, California, USA

11:30   Psychology of Patients and Caregivers

Korey Hood, PhD
Stanford University, Stanford, California, USA

William Polonsky, PhD, CDCES
Behavioral Diabetes Institute, San Diego, California, USA

12:00   Lunch

Session 2: Response

Outpatient Care

Moderator

David Ahn, MD
Hoag Hospital, Newport Beach, California, USA

13:05   Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention

Nicholas Argento, MD, FACE
Maryland Endocrine, Columbia, Maryland, USA

Frank Best, MD
Die Diabetes-Praxis, Essen, Germany

Anders Carlson, MD
Park Nicollet International Diabetes Center, Minneapolis, Minnesota, USA

Curtiss Cook, MD
Mayo Clinic Arizona, Scottsdale, Arizona, USA

Deborah Wake, PhD
University of Dundee, NHS Tayside, Dundee, Scotland, UK

14:05   Technology and Telemedicine for DM Patients

Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway

Juan Espinoza, MD, FAAP
Children's Hospital Los Angeles, USC, Los Angeles, California, USA

Aaron Neinstein, MD
UCSF, San Francisco, California, USA

Kirsten Nørgaard, MD, DMSc
Steno Diabetes Center, Copenhagen, Denmark

15:05   Break

Inpatient Care

Moderator

Amisha Wallia, MD, MS
Northwestern University, Chicago, Illinois, USA

15:30   Technology for Inpatients

Joseph Aloi, MD
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

Kathleen Dungan, MD, MPH
Ohio State University, Columbus, Ohio, USA

Elias Spanakis, MD
University of Maryland School of Medicine, Baltimore, Maryland, USA

15:50   Management of Diabetes Inpatients with COVID-19

Shivani Agarwal, MD, MPH
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA

Joshua Miller, MD, MPH
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA

Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA

Robert Rushakoff, MD
UCSF, San Francisco, California, USA

16:30   Ethics

Jacob M Appel, MD, JD, MPH
Icahn School of Medicine at Mount Sinai, New York City, New York, USA

James Tabery, PhD
University of Utah, Salt Lake City, Utah, USA

17:00   Adjourn

Thursday, August 27, 2020

8:00     Opening Remarks

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

8:05     Keynote

William Cefalu, MD
NIH, National Institute of Diabetes and Digestive and Kidney Diseases,
Bethesda, Maryland, USA

Session 3: Recovery

Resources

Moderator

Elias Spanakis, MD
University of Maryland School of Medicine, Baltimore, Maryland, USA

8:15     Accuracy of Diagnostic Tests

Jonathan Schmitz, MD, PhD
Vanderbilt University, Nashville, Tennessee, USA

Nam Tran, PhD
UC Davis, Sacramento, California, USA

8:35     Children

Zoltan Antal, MD
Weill Cornell Medicine, New York, New York

Jennifer Raymond, MD, MCR
Children's Hospital Los Angeles, USC, Los Angeles, California, USA

8:55     Pregnancy

James Bernasko, MD
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA

Lynn Yee, MD, MPH
Northwestern University, Chicago, Illinois, USA

9:15     Economics of Care for COVID-19

Lynn Barr, MPH
Caravan Health, Kansas City, Missouri, USA

Ronald Goodstein, PhD
Georgetown University, Washington, DC

Wei-An (Andy) Lee, DO
Los Angeles County+USC Medical Center, Los Angeles, California, USA

Ateev Mehrotra, MD, MPH
Harvard University, Boston, Massachusetts, USA

10:05   Break

High Risk Groups

Moderator

Lauren Wisk, PhD
UCLA, Los Angeles, California, USA

10:30   Role of Industry

Sponsors

11:20   Protection of Healthcare Workers

Marissa Baker, PhD
University of Washington, Seattle, Washington, USA

Shuhan He, MD
Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA

David Weissman, MD
CDC National Institute for Occupational Safety and Health, Washington, DC

11:50   Patients

TBD

12:10   Lunch

Session 4: Surveillance

Regulation

Moderator

Kong Chen, PhD, MSCI
NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA

13:15   International Responses to COVID-19

Patricia Gomez, MD
Universidad de Chile, Santiago, Chile

David O’Neal, MD, FRACP
St. Vincent's Hospital, University of Melbourne, Victoria, Melbourne, Australia

Gerry Rayman, MD, FRCP
NHS England, Richmond House, London, England

Eun-Jung Rhee, MD, PhD
Kangbuk Samsung Hospital, Seoul, South Korea

Laurien Sibomana, MS
Rwandan Diabetes Association, Kigali, Rwanda, Africa

Kayo Waki, MD, MPH, PhD
University of Tokyo Graduate School of Medicine, Tokyo, Japan

13:45   Government Policy

Paul Gerrard, MD
McDermott+Consulting, Washington, DC

Venkat Narayan, MD, MSc, MBA
Emory University, Atlanta, Georgia, USA

Bruce Quinn, MD, PhD
Bruce Quinn Associates LLC, Los Angeles, California, USA

14:25   Regulation of Tests and Treatments

Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia, USA

Alberto Gutierrez, PhD
NDA Partners LLC, Rochelle, Virginia, USA

Yarmela Pavlovic, JD
Manatt Health, San Francisco, California, USA

14:55   Break

The Future

Moderator

Gerard Coté, PhD
Texas A&M University, College Station, Texas, USA

15:20   Digital Health Technology

Bill Evans, BA
Rock Health, San Francisco, California, USA

Jessie Juusola, PhD
Evidation Health, San Mateo, California, USA

Kuldeep Singh Rajput, PhD
Biofourmis, Boston, Massachusetts, USA

16:00   Big Data Statistics

Christina Astley, MD, ScD
Boston Children’s Hospital, Harvard University, Boston, Massachusetts, USA

Malik Magdon-Ismail, PhD, MS
Rensselaer Polytechnic Institute, Troy, New York, USA

16:20   Patient Surveillance and Privacy

David A Drew, PhD
Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA

T.S. Harvey, PhD
Vanderbilt University, Nashville, Tennessee, USA

Dave Kleidermacher, BS
Google, Mountain View, California, USA

Elissa Weitzman, ScD, MSc
Boston Children's Hospital, Harvard University, Boston, Massachusetts, USA

16:50   What Have We Learned?

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

17:00   Adjourn